Adverse events occurring after SARS-CoV- 2 vaccination have been reported and are the subject of ongoing research. We present the case of a young woman with fully reversible radiculomyelitis, which happened after the first dose of the ChAdOx1 nCOVID-19 vaccine. A previously healthy woman in her 20s presented with a subacute onset of legs’ weakness and sensory disturbances, urinary dysfunction and cramping pain after receiving the first dose of the ChAdOx1 nCoV-19 vaccine. A diagnostic workup led to the diagnosis of inflammatory radiculomyelitis. Her clinical status improved, with complete recovery after a few months. The case described a reversible radiculomyelitis associated with the ChAdOx1 nCOVID-19 vaccine. The clinical picture and evolution supported the diagnosis. No other identifiable causes of myelopathy were found. Our patient showed clinically moderate symptoms and signs, showing good recovery. The post-vaccine inflammatory radiculomyelitis is a rare side effect of the anti-COVID- 19 vaccination, and it should not discourage the SARS-CoV- 2 vaccination programme
spataro r, f.g. (2022). Reversible radiculomyelitis after ChAdOx1 nCoV-19 vaccination. BMJ CASE REPORT, 15(2), 1-4 [10.1136/bcr-2021-247472].
Reversible radiculomyelitis after ChAdOx1 nCoV-19 vaccination
la bella v
Ultimo
Supervision
2022-02-01
Abstract
Adverse events occurring after SARS-CoV- 2 vaccination have been reported and are the subject of ongoing research. We present the case of a young woman with fully reversible radiculomyelitis, which happened after the first dose of the ChAdOx1 nCOVID-19 vaccine. A previously healthy woman in her 20s presented with a subacute onset of legs’ weakness and sensory disturbances, urinary dysfunction and cramping pain after receiving the first dose of the ChAdOx1 nCoV-19 vaccine. A diagnostic workup led to the diagnosis of inflammatory radiculomyelitis. Her clinical status improved, with complete recovery after a few months. The case described a reversible radiculomyelitis associated with the ChAdOx1 nCOVID-19 vaccine. The clinical picture and evolution supported the diagnosis. No other identifiable causes of myelopathy were found. Our patient showed clinically moderate symptoms and signs, showing good recovery. The post-vaccine inflammatory radiculomyelitis is a rare side effect of the anti-COVID- 19 vaccination, and it should not discourage the SARS-CoV- 2 vaccination programmeFile | Dimensione | Formato | |
---|---|---|---|
BMJ Case Reports - 2022.pdf
Open Access dal 01/03/2024
Tipologia:
Versione Editoriale
Dimensione
257.96 kB
Formato
Adobe PDF
|
257.96 kB | Adobe PDF | Visualizza/Apri |
10447-585370_BMJ_MS_submitted_-_preprint.pdf
accesso aperto
Descrizione: pre-print
Tipologia:
Pre-print
Dimensione
148.81 kB
Formato
Adobe PDF
|
148.81 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.